Entero Healthcare Solutions Limited (NSE:ENTERO)

India · Delayed Price · Currency is INR

1,238.30

+0.60 (0.05%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Trading of Pharmaceutical and Surgical Products	50.96B	39.22B	33.00B	25.22B	17.73B
Trading of Pharmaceutical and Surgical Products Growth	29.92%	18.85%	30.85%	42.24%	31.38%
Total	50.96B	39.22B	33.00B	25.22B	17.73B
Total Growth	29.92%	18.85%	30.85%	42.24%	31.38%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	50.96B	39.22B	33.00B	-	17.70B
India Growth	29.92%	18.85%	-	-	31.18%
Export	-	-	-	-	27.06M
Total	50.96B	39.22B	33.00B	-	17.73B
Total Growth	29.92%	18.85%	-	-	31.38%

Source: S&P Global Market Intelligence.